|
|
|
|
| LEADER |
04360nmm a2200301 u 4500 |
| 001 |
EB000670884 |
| 003 |
EBX01000000000000000523966 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642707025
|
| 100 |
1 |
|
|a Hippius, Hans
|e [editor]
|
| 245 |
0 |
0 |
|a New Results in Depression Research
|h Elektronische Ressource
|c edited by Hans Hippius, Gerald L. Klerman, N. Matussek
|
| 250 |
|
|
|a 1st ed. 1986
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1986, 1986
|
| 300 |
|
|
|a 2 illus
|b online resource
|
| 505 |
0 |
|
|a Murnau and the History of Psychiatry -- Evidence for Increase in Rates of Depression in North America and Western Europe in Recent Decades -- The Affective Disorders: Results from the Epidemiologic Catchment Area Study (ECA) -- The Course of Major Depression, Atypical Bipolar Disorder, and Bipolar Disorder -- Validating Depressive Subtypes -- Personality and Bipolar Disorder -- Self-Report Inventories in the Study of Depression -- Bereavement and Its Relation to Clinical Depression -- Familial Classification of Depressive Illnesses -- Recent Genetic Findings in Mood Disorders -- Repeated Treatment with Antidepressant Drugs: Responses Mediated by Brain Dopamine Receptors -- Latest Findings in the Treatment of Depression -- Treatment of Atypical Depression: Phenelzine, Imipramine, and Placebo -- Biology, Therapeutics, and Prophylaxis in Recurrent Depression -- Reduced Lithium Dosage Improves Prophylaxis: A Possible Mechanism. -- Effects of Lithium on Cell Membranes: Relation to Prophylactic Response. -- Dimensional Classification as an Instrument for Biological Research in Endogenous Depression -- Biochemical Markers of Serotonin Functions in Depression and Suicidal Behavior -- A Biochemical and Neuroendocrine Study of the Serotonergic System in Depression -- Responses to Clonidine in Acute and Remitted Depressed Patients -- Investigations of the Cholinergic-Adrenergic Balance in Affective Disorders. -- The Role of the Hypothalamus-Pituitary-Adrenocortical System in Depression. -- Studies of the Hypothalamus-Pituitary-Adrenocortical System: An Example of Progress in Psychoneuroendocrinology -- Pharmacoendocrine Studies in Health Subjects and Depressed Patients
|
| 653 |
|
|
|a Psychiatry
|
| 653 |
|
|
|a Psychiatry
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 700 |
1 |
|
|a Klerman, Gerald L.
|e [editor]
|
| 700 |
1 |
|
|a Matussek, N.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-70702-5?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615
|
| 520 |
|
|
|a The improvements in treatment for depression as reviewed here are based on: 1. New developments in the realm of antidepressive medication, involving the use of second-generation antidepressants; treatment with precursors; new forms of treatment by intravenous drip infusion; and a new approach to long-term pro phylactic therapy entailing administration of an anti-epileptic agent. 2. Improved psychotherapeutic procedures employed as an accompaniment to antidepressive medication; correction of errors liable to be committed in the conduct of psychotherapy; clarification of the indications for group, family, or behavioral therapy and psychoanalysis. New psychotherapeutic methods allow conversational therapy to be more closely adapted to the patient's indi vidual needs and render it more effective. 3. New findings relating to diagnosis and monitoring of the clinical course with the help of biological markers. Although no specific markers have yet been dis covered, the markers now available do make it possible to establish a more ac curate differential diagnosis of the various types of depression. Moreover, in individual cases of depression, the response to treatment can often be more sat isfactorily monitored by resorting to state-dependent markers. A clear-cut biological classification of depressive states would in certain types of depression make it feasible in the near future to administer substitution treat ment with precursors and later possibly even to provide causal therapy. Discussion In supplement to this comprehensive survey, findings were reported which may support the hypothesis that the cortisol escape after dexamethasone could be a trait variable
|